Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOBENZAPRINE Cause Wheezing? 125 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Wheezing have been filed in association with CYCLOBENZAPRINE (Cyclobenzaprine hydrochloride). This represents 1.4% of all adverse event reports for CYCLOBENZAPRINE.

125
Reports of Wheezing with CYCLOBENZAPRINE
1.4%
of all CYCLOBENZAPRINE reports
113
Deaths
74
Hospitalizations

How Dangerous Is Wheezing From CYCLOBENZAPRINE?

Of the 125 reports, 113 (90.4%) resulted in death, 74 (59.2%) required hospitalization, and 75 (60.0%) were considered life-threatening.

Is Wheezing Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOBENZAPRINE. However, 125 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOBENZAPRINE Cause?

Toxicity to various agents (1,854) Pain (1,494) Completed suicide (1,438) Drug hypersensitivity (1,094) Constipation (1,057) Drug ineffective (954) Drug abuse (873) Off label use (800) Fall (796) Hypotension (769)

What Other Drugs Cause Wheezing?

ALBUTEROL (11,555) PREDNISONE (8,152) MEPOLIZUMAB (6,093) BUDESONIDE\FORMOTEROL (5,632) TIOTROPIUM (5,361) MONTELUKAST (5,159) OMALIZUMAB (4,522) FLUTICASONE\SALMETEROL (3,948) RITUXIMAB (3,145) CICLESONIDE (2,785)

Which CYCLOBENZAPRINE Alternatives Have Lower Wheezing Risk?

CYCLOBENZAPRINE vs CYCLOPENTOLATE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE

Related Pages

CYCLOBENZAPRINE Full Profile All Wheezing Reports All Drugs Causing Wheezing CYCLOBENZAPRINE Demographics